Reported 3 days ago
HCW Biologics Inc (NASDAQ:HCWB) experienced a significant stock surge during Monday's premarket trading, rising 237% to $0.99 with a remarkable volume of 10.03 million shares. This spike follows the announcement of an exclusive licensing agreement with WY Biotech Co., Ltd., which entails a $7 million upfront payment to HCW for the development and commercialization of a therapeutic candidate. This partnership could bolster HCW's financial position, although the company previously expressed concerns about its ability to continue operations without additional funding.
Source: YAHOO